[PDF][PDF] Mutasi dan Varian Coronavirus Disease 2019 (COVID-19): Tinjauan Literatur Terkini

A Susilo, COM Jasirwan, S Wafa, S Maria… - Jurnal Penyakit …, 2022 - researchgate.net
ABSTRAK Pandemi Coronavirus disease 2019 (COVID-19) telah berlangsung sejak Maret
2020 hingga saat ini sudah hampir dua tahun melanda dunia, tak terkecuali Indonesia …

[HTML][HTML] Delta variant: the new challenge of COVID-19 pandemic, an overview of epidemiological, clinical, and immune characteristics

R Rashedi, N Samieefar, M Akhlaghdoust… - Acta Bio Medica …, 2022 - ncbi.nlm.nih.gov
The SARS-CoV-2 genome has undergone several mutations since the beginning of the
pandemic in December 2019. A number of these mutants were associated with higher …

Need of booster vaccine doses to counteract the emergence of SARS-CoV-2 variants in the context of the Omicron variant and increasing COVID-19 cases: An update

RK Mohapatra, NA El-Shall, R Tiwari… - Human Vaccines & …, 2022 - Taylor & Francis
The emergence of different variants of SARS-CoV-2, including the Omicron (B. 1.1. 529)
variant in November 2021, has resulted in a continuous major health concern at a global …

Convalescent serum-derived exosomes: Attractive niche as COVID-19 diagnostic tool and vehicle for mRNA delivery

A Krishnan, P Gangadaran… - Experimental …, 2022 - journals.sagepub.com
The spread of SARS-CoV-2 over the entire world is more commonly known as COVID-19.
COVID-19 has impacted society in every aspect of routine life. SARS-CoV-2 infection is often …

[HTML][HTML] COVID-19 therapy and vaccination: a clinical narrative review

S Chinta, M Rodriguez-Guerra, M Shaban… - Drugs in …, 2023 - ncbi.nlm.nih.gov
The SARS-CoV-2 pandemic is the most globally impacting health issue our world has faced
over the last century. As of January 7, 2022, around 300 million cases have been reported …

[HTML][HTML] Evolving trend change during the COVID-19 pandemic

L Gao, C Zheng, Q Shi, K Xiao, L Wang, Z Liu… - Frontiers in public …, 2022 - frontiersin.org
Coronavirus disease (COVID-19) has caused unimaginable damage to public health and
socio-economic structures worldwide; thus, an epidemiological depiction of the global …

[HTML][HTML] Selection and validation of siRNAs preventing uptake and replication of SARS-CoV-2

M Friedrich, G Pfeifer, S Binder, A Aigner… - … in bioengineering and …, 2022 - frontiersin.org
In 2019, the novel highly infectious severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) outbreak rapidly led to a global pandemic with more than 346 million confirmed …

COVID-19 and diabetes: What do we know so far?

P Gangadaran, H Padinjarathil… - Experimental …, 2022 - journals.sagepub.com
Coronavirus disease 2019 (COVID-19) management has been challenging for patients with
comorbidities. Patients with diabetes and COVID-19, in particular, have shown severe …

[HTML][HTML] PAD inhibitors as a potential treatment for SARS-CoV-2 immunothrombosis

W Elliott Jr, MR Guda, S Asuthkar, N Teluguakula… - Biomedicines, 2021 - mdpi.com
Since the discovery of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in
December 2019, the virus's dynamicity has resulted in the evolution of various variants …

Is COVID-19-associated cytokine storm distinct from non-COVID-19 secondary hemophagocytic lymphohistiocytosis?

JM Liu, J Chi - Experimental Biology and Medicine, 2022 - journals.sagepub.com
Cytokine storm is an umbrella term that describes an inflammatory syndrome characterized
by elevated levels of circulating cytokines and hyperactivation of innate and/or adaptive …